RegenBio Pharmaceuticals Inc.

Cambridge, USA stryker.com

Overview

RegenBio Pharmaceuticals Inc. is a biotechnology company focused on developing regenerative medicine solutions. The company is dedicated to leveraging advanced technologies to address a variety of unmet medical needs through innovative therapies.

Therapeutic areas

OncologyNeurologyCardiologyRegenerative Medicine

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to RegenBio Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

3D Imaging Drug Design and Development LLC
United States
A&B Pharmaceuticals
United States
ActiPharma Incorporated
United States
AD Pharmaceuticals Inc.
USA
Ads Biosystems Inc.
United States
Advanced Diagnostics Inc.
USA
AltaPharma Incorporated
United States
Amneal Pharmaceuticals
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo